Article Details

GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Retrieved on: 2024-04-25 13:23:10

Tags for this article:

Click the tags to see associated articles and topics

GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar. View article details on hiswai:

Summary

The article highlights GRI Bio, Inc., a biotech company, presenting at an investment webinar hosted by Webull. The company specializes in modulating Natural Killer T (NKT) cells to treat inflammatory, fibrotic, and autoimmune diseases. Relevant tags include immunology, immune system, T cells, autoimmunity, and inflammation.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up